Sputnik Images media library

info@sputnikimages.com / +7 495 637 35 19

Science & Technology

Russia Coronavirus Antiviral Drug
#6444074

Russia Coronavirus Antiviral Drug

An employee works in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444060

Russia Coronavirus Antiviral Drug

An employee works in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444072

Russia Coronavirus Antiviral Drug

Employees work in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444078

Russia Coronavirus Antiviral Drug

An employee works in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444073

Russia Coronavirus Antiviral Drug

Employees work in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444076

Russia Coronavirus Antiviral Drug

An employee works in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444077

Russia Coronavirus Antiviral Drug

Employees work in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444066

Russia Coronavirus Antiviral Drug

the view shows the ampoules of the antiviral drug Rediform at the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444079

Russia Coronavirus Antiviral Drug

An employee works in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444069

Russia Coronavirus Antiviral Drug

Governor of the Irkutsk region Igor Kobzev, left background, visits the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444070

Russia Coronavirus Antiviral Drug

From left, General Director of JSC "Pharmasintez" Evgeny Orachevsky, President of the group of companies "Pharmasintez" Vikram Punia and Governor of the Irkutsk region Igor Kobzev are pictured at the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

Russia Coronavirus Antiviral Drug
#6444071

Russia Coronavirus Antiviral Drug

An employee works in the physical-chemical laboratory of quality control at the Russian drugmaker Pharmasyntez in Irkutsk, Russia. The first large shipment of the drug to combat COVID-19 "Rediform", a generic version of U.S. COVID-19 drug Remdesivir, is ready for release. Remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration in May after it was shown to shorten hospital stays for COVID-19 patients in a government-run clinical trial.

An unexpected error has occurred. If the problem persists, please contact support.